Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose study

https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00216-3/abstract?utm_campaign=update-laneur&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_laneur&_hsenc=p2ANqtz-97fhgd1SCcnTEb-QgLEulHkpu8IGFr-lPEA2tY9wBg8rSlZCvpl_gkxOiKUhZGlzR-FtwQKHQ1tQw4pOhDACPQcN-_GQ&_hsmi=322932634&utm_content=322876396&utm_source=hs_email